heart failure

Highlights: 2019 Cardiometabolic Health Congress West
Highlights: 2019 Cardiometabolic Health Congress West
CP Wire
diabetes
heart disease
cardiometabolic health
heart failure
cardiovascular disease
Flag link:
Highlights: 2019 Cardiometabolic Health Congress West
diabetes
heart disease
cardiometabolic health
heart failure
Flag link:
ED Drug Shows Promise in Sheep Heart Failure Study
ED Drug Shows Promise in Sheep Heart Failure Study
BioSpace
heart failure
tadalafil
Pfizer
Viagra
Eli Lilly
Cialis
Flag link:
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure
Flag link:
Amgen, Servier heart failure drug clears trial hurdle
Amgen, Servier heart failure drug clears trial hurdle
PM Live
Amgen
Servier
heart failure
Omecamtiv Mecarbil
clinical trials
Flag link:
American College of Cardiology Conference Roundup - day 1
American College of Cardiology Conference Roundup - day 1
CP Wire
American College of Cardiology
Novartis
Entresto
heart failure
Edwards Lifesciences
Apple
TAVR
wearables
clinical trials
Apple Watch
atrial fibrillation
Flag link:
American College of Cardiology Conference Roundup - day 1
American College of Cardiology
Novartis
Entresto
heart failure
Edwards Lifesciences
Apple
TAVR
wearables
clinical trials
Apple Watch
atrial fibrillation
Flag link:
ACC 2019 preview – Bayer hopes for heart failure panache
ACC 2019 preview – Bayer hopes for heart failure panache
EP Vantage
Bayer
heart failure
Amarin
Esperion
ACC
Vascepa
bempedoic acid
Flag link:
Mesoblast defends stem cell therapy for heart failure after trial miss
Mesoblast defends stem cell therapy for heart failure after trial miss
Fierce Biotech
Mesoblast
stem cells
clinical trials
heart failure
Flag link:
AstraZeneca's diabetes drug curbs heart failure, kidney risks
AstraZeneca's diabetes drug curbs heart failure, kidney risks
Yahoo/Reuters
AstraZeneca
Farxiga
diabetes
heart failure
Flag link:
Arena preparing for trials of first-in-class heart failure drug
Arena preparing for trials of first-in-class heart failure drug
Fierce Biotech
Arena Pharma
decompensated heart failure
heart failure
APD418
Flag link:
Perspective: A Heart Device Can Save Lives, But Doctors Need To Explain The Downsides
Perspective: A Heart Device Can Save Lives, But Doctors Need To Explain The Downsides
NPR
devices
LVAD
physicians
heart failure
Flag link:
Ironwood secures FDA fast track designation for heart drug praliciguat
Ironwood secures FDA fast track designation for heart drug praliciguat
Pharmaceutical Business Review
Ironwood Pharmaceuticals
FDA
praliciguat
heart failure
Flag link:
BioCardia touts preliminary data from heart failure trial
BioCardia touts preliminary data from heart failure trial
Drug Delivery Business News
BioCardia
devices
heart failure
CardiAMP
Flag link:
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
ADA: J&J's Invokana and rivals cut heart failure hospitalizations without increasing amputation risk
Fierce Pharma
JNJ
Invokana
diabetes
heart failure
Flag link:
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
CP Wire
BioCardia
CardiAMP
heart failure
clinical trials
Flag link:
BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal
BioCardia
CardiAMP
heart failure
Flag link:
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Lilly, Boehringer add two Jardiance heart failure studies to examine effects on exercise
Fierce Pharma
Eli Lilly
Boehringer Ingelheim
Jardiance
heart failure
exercise
diabetes
Flag link:
Heart group warns of cardiovascular risks after treatment for breast cancer
Heart group warns of cardiovascular risks after treatment for breast cancer
Stat
breast cancer
heart failure
chemotherapy
heart disease
Flag link:
One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology
One big Novartis takeaway from Entresto's slow start? Heart failure doesn't work like oncology
Fierce Pharma
Novartis
Entresto
drug launches
heart failure
oncology
Flag link:

Pages